Unique ID issued by UMIN | UMIN000000769 |
---|---|
Receipt number | R000000925 |
Scientific Title | Assessment of efficacy and safety of immunotherapy for unresectable locally advanced pancreatic cancer. |
Date of disclosure of the study information | 2007/09/01 |
Last modified on | 2015/02/12 09:46:57 |
Assessment of efficacy and safety of immunotherapy for unresectable locally advanced pancreatic cancer.
Immunotherapy for pancreatic cancer.
Assessment of efficacy and safety of immunotherapy for unresectable locally advanced pancreatic cancer.
Immunotherapy for pancreatic cancer.
Japan |
pancreatic ductal carcinoma
Hepato-biliary-pancreatic medicine |
Malignancy
NO
Confirmation of efficacy
Safety
Exploratory
Pragmatic
Phase I,II
OS
TTP
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine | Maneuver |
Endoscopic therapy
20 | years-old | <= |
75 | years-old | >= |
Male and Female
Unresectable locally advanced pancreatic cancer with pathological evidence
Patients with immunologic abnormalities
15
1st name | |
Middle name | |
Last name | Yoshiki Hirooka |
Nagoya University Hospital
Department of Endoscopy
65,Tsuruma-Cho,Showa-Ku,Nagoya City
052-752-9882
hirooka@med.nagoya-u.ac.jp
1st name | |
Middle name | |
Last name | Yoshiki Hirooka |
Nagoya University Hospital
Department of Endoscopy
65, Tsuruma-Cho, Showa-Ku
052-744-2602
hirooka@med.nagoya-u.ac.jp
Nagoya University Hospital
Nagoya University Graduate School of Medicine
Seta-Clinic Shin-Yokohama
MEDINET Co.,Ltd.
NO
2007 | Year | 09 | Month | 01 | Day |
Unpublished
No longer recruiting
2007 | Year | 07 | Month | 02 | Day |
2007 | Year | 08 | Month | 01 | Day |
2015 | Year | 03 | Month | 31 | Day |
2007 | Year | 07 | Month | 13 | Day |
2015 | Year | 02 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000925